Becton, Dickinson and Company (BDX)
-NYSE 100.83 
0.66(0.66%) May 24, 4:00PM EDT|After Hours
:
100.83 0.00 (0.00%) May 24, 4:20PM EDT
| Prev Close: | 100.17 |
|---|
| Open: | 99.57 |
|---|
| Bid: | 88.00 x 100 |
|---|
| Ask: | 103.34 x 100 |
|---|
| 1y Target Est: | 97.67 |
|---|
| Beta: | 0.83 |
|---|
| Next Earnings Date: | 2-Aug-13 |
|---|
| Day's Range: | 99.02 - 100.85 |
|---|
| 52wk Range: | 71.56 - 102.72 |
|---|
| Volume: | 835,051 |
|---|
| Avg Vol (3m): | 1,103,070 |
|---|
| Market Cap: | 19.59B |
|---|
| P/E (ttm): | 13.43 |
|---|
| EPS (ttm): | 7.51 |
|---|
| Div & Yield: | 1.98 (2.00%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BD to Present at the Deutsche Bank 38th Annual Health Care ConferencePR Newswire(Fri, May 24)
- Patterson Cos Posts In-Line EarningsZacks(Thu, May 23)
- A Moderate-Risk, High-Reward Dividend Playat Seeking Alpha(Wed, May 22)
- BSX Entangled in Patent IssuesZacks(Wed, May 22)
- Wright Medical Stays NeutralZacks(Wed, May 22)
- BD Issues 2012 Sustainability ReportPR Newswire(Wed, May 22)
- THOR Downgraded to UnderperformZacks(Tue, May 21)
- BD Board Declares DividendPR Newswire(Tue, May 21)
- FDA Nod for Thoratec ControllerZacks(Mon, May 20)
- PKI Downgraded to UnderperformZacks(Mon, May 20)
- July Options Now Available For Becton, Dickinson And Co. (BDX)at TheStreet(Mon, May 20)
- The Top 35 Dividend Champions With Regard To Long-Term Stock Price Appreciationat Seeking Alpha(Sun, May 19)
- Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bondsat Seeking Alpha(Fri, May 17)
- 4 Stocks Driving The Health Services Industry Higherat TheStreet(Fri, May 17)
- Wall Street Transcript Interview with Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd.: A Health Sciences Fund with a Long-Term FocusWall Street Transcript(Fri, May 17)
Key Statistics
| Forward P/E (1 yr): | 16.03 |
|---|
| P/S (ttm): | 2.48 |
|---|
| Ex-Dividend Date: | 05-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 5.75 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.48 |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 1.94 |
|---|
Business Summary
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
View More